Table 1.

Pertinent findings of the patients before and post liraglutide administration.

	Before	Post-liraglutide Rx	P
Weight (kg)	92.80 ± 13.78	89.25 ± 6.10	0.13
BMI (kg/m2)	31 ± 3.51	30 ± 2.83	0.28
Total Fat (%)	43.12 ± 4.69	39.25 ± 1.37	0.035
Trunk Fat (%)	42.32 ± 4.96	37.00 ± 1.58	0.019
Menstrual cycles/year	6 ± 0.81	10.33 ± 0.88	0.002
FG-score	12.25 ± 1.25	8.75 ± 0.47	0.003
Cholesterol (mg/dL)	186.51 ± 10.47	172.23 ± 13.56	0.26
HDL (mg/dL)	41.75 ± 4.62	38.23 ± 5.72	0.34
LDL (mg/dL)	108.81 ± 5.12	112.64 ± 6.23	0.28
Triglycerides (mg/dL)	168.3 ± 13.82	161.47 ± 12.87	0.31
Glucose (mg/dL)	85.25 ± 5.25	87.75 ± 7.00	0.43
Insulin (pmol/L)	39.25 ± 4.820	22.44 ± 5.368	0.0006
HOMA-IR	8.388 ± 1.327	5.118 ± 1.437	0.0003
AUC GLU	15065 ± 1833	15818 ± 3659	0.82
AUC INS	23764 ± 2467	17723 ± 3341	0.021
MATSUDA index	1.015 ± 0.061	1.44 ± 0.25	0.25
FSH (IU/L)	4.70 ± 0.63	4.55 ± 0.33	0.34
LH (IU/L)	6.52 ± 2.52	5.82 ± 0.68	0.46
E2 (pg/mL)	49.63 ± 6.27	45.14 ± 7.64	0.62
Testosterone (ng/dL)	1.02 ± 0.08	0.63 ± 0.12	0.027
SHBG (nmol/L)	28.50 ± 0.66	25.23 ± 8.82	0.34
Androstenedione (ng/dL)	3.17 ± 0.34	2.65 ± 0.49	0.03
DHEAS(μg/dL)	274 ± 4.62	238 ± 38.43	0.31
170HP (ng/dL)	0.95 ± 0.052	0.84 ± 0.043	0.28